DTC

Developmental Therapeutics Consortium (DTC) is a biotechnology company focused on the development of novel therapeutic agents for the treatment of cancer. The company leverages a collaborative model to advance early-stage oncology programs through clinical development. DTC's portfolio includes a range of small molecules and biologics targeting key pathways in tumor growth and survival. By partnering with academic institutions and pharmaceutical companies, DTC aims to accelerate the delivery of innovative cancer treatments to patients. The company's expertise spans drug discovery, preclinical evaluation, and early-phase clinical trials.